Medication info
New Masartan Tablets 10mg (Olmesartan Medoxomil)

New Masartan Tablets 10mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201507878 · Approved 2015.11.25 · Insurance code 669906520

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
1. Adults The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective circulating blood volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This drug is used to control essential hypertension to maintain heart and vascular health by normalizing blood pressure. It effectively manages hypertension and helps prevent complications such as heart attacks and strokes. Using it alongside consistent medication and lifestyle improvements enhances treatment effects. It improves overall cardiovascular health through hypertension management.

How to take

Adult dose

1. Adults The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective circulating blood volume (Intravascular volume depletion) (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. As there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn when taken during the second or third trimesters of pregnancy, so treatment should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver impairment, or patients with biliary obstruction should not take this drug. Since this medication contains lactose, patients with genetic disorders such as galactose intolerance or lactase deficiency should not take it. Patients with low blood volume or reduced salt levels may experience low blood pressure when starting this medication, so appropriate measures should be taken before taking it, and their condition should be closely monitored. This medication may affect kidney function, so patients with impaired kidney function should frequently check their kidney status through blood tests and should avoid using it in cases of severe kidney impairment. There is a risk of hyperkalemia, so patients with heart or kidney disease should periodically test their serum potassium levels. Patients with aortic or mitral stenosis and obstructive cardiomyopathy should take special precautions while using this medication, as blood pressure reduction may cause dizziness, so they should avoid driving or operating hazardous machinery. Common mild side effects include dizziness, headaches, dyspepsia, muscle pain, and rashes, while rare serious side effects such as angioedema or abnormal liver function have also been reported. If symptoms of gastrointestinal disease accompanied by chronic diarrhea and weight loss appear, discontinue use of this medication and consult a physician. Co-administration with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory analgesics may increase the risk of side effects due to interactions, so consult medical professionals when combining. Pregnant women should avoid this medication due to the risk of fetal harm, and breastfeeding women should carefully consider whether to take it due to the potential for adverse reactions in infants. Safety in children has not been established; hence, it is not recommended for use in children. Elderly patients should exercise caution when taking this medication, as its concentration in the body may increase.

Side effects

  • Dizziness
  • lower back pain
  • bronchitis
  • increase in creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • increased serum creatinine
  • hair loss
  • itching
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • upper respiratory infection
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 to 25 degrees Celsius. This helps to preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.